Page last updated: 2024-09-04

tx 3301 and thromboxane b2

tx 3301 has been researched along with thromboxane b2 in 1 studies

Compound Research Comparison

Studies (tx 3301)	Trials (tx 3301)	Recent Studies (post-2010) (tx 3301)	Studies (thromboxane b2)	Trials (thromboxane b2)	Recent Studies (post-2010) (thromboxane b2)
69	15	16	7,483	715	485

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Byrne, MF; Conroy, R; Cox, D; Dooley, M; Fitzgerald, DJ; Maree, AO	1

Trials

1 trial(s) available for tx 3301 and thromboxane b2

Article	Year
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers. Stroke, 2006, Volume: 37, Issue:8 Topics: Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Body Weight; Cross-Over Studies; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Humans; Logistic Models; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Tablets, Enteric-Coated; Therapeutic Equivalency; Thromboxane B2; Treatment Outcome	2006

Article

Year

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.

Stroke, 2006, Volume: 37, Issue:8

Topics: Adult; Aspirin; Aspirin, Dipyridamole Drug Combination; Body Weight; Cross-Over Studies; Dipyridamole; Dose-Response Relationship, Drug; Drug Combinations; Humans; Logistic Models; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Reference Values; Tablets, Enteric-Coated; Therapeutic Equivalency; Thromboxane B2; Treatment Outcome

2006